The Head of Business Development, Europe will lead all business development activities across the region across generics, complex generics, established brands, mature brands nearing loss of exclusivity (LOE), and innovative brands. This role brings a strategic mindset to transform and accelerate growth and profitability through portfolio mix, differentiated partnerships, and creative deal structures. Work cross-functionally with Commercial, R&D, and Operations to ensure opportunities are commercially viable, scientifically sound, and operationally executable.
Responsibilities:
- Partner with European Commercial leadership to align BD activities with portfolio gaps and market priorities.
- Define and execute the European BD strategy with emphasis on generics, complex generics, established brands, mature brands nearing LOE, and innovative brand opportunities.
- Anticipate market evolution and identify next-stage innovation in generics and established brands (delivery models, lifecycle management, deal-making).
- Identify and pursue licensing and strategic partnerships in Europe to strengthen core generics and established brand portfolio.
- Evaluate opportunities on financial/commercial terms and strategic impact.
- Lead negotiations and due diligence with Legal, Finance, R&D, Regulatory, and Operations.
- Collaborate with Global BD leadership to inform global growth strategies.
- Lead and mentor a European BD team.
Qualifications/Skills:
- 8β12+ years in business development or corporate strategy in pharmaceuticals; significant European market expertise.
- Deep knowledge of European generics, complex generics, established brands, and innovative brand strategies.
- Proven success in mid- to large-scale BD transactions (licensing, partnerships) with measurable impact.
- Strategic thinking about market evolution and innovation in mature pharma.
- Strong cross-functional collaboration (Commercial and Regulatory).
- Excellent negotiation, communication, and leadership; fluent in English (other European languages a plus).